chr1-230067374-G-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate

The NM_004481.5(GALNT2):​c.94G>T​(p.Ala32Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000000866 in 1,154,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 8.7e-7 ( 0 hom. )

Consequence

GALNT2
NM_004481.5 missense

Scores

2
17

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 3.61

Publications

0 publications found
Variant links:
Genes affected
GALNT2 (HGNC:4124): (polypeptide N-acetylgalactosaminyltransferase 2) This gene encodes a member of the glycosyltransferase 2 protein family. Members of this family initiate mucin-type O-glycoslation of peptides in the Golgi apparatus. The encoded protein may be involved in O-linked glycosylation of the immunoglobulin A1 hinge region. This gene may influence triglyceride levels, and may be involved Type 2 diabetes, as well as several types of cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
GALNT2 Gene-Disease associations (from GenCC):
  • congenital disorder of glycosylation, type iit
    Inheritance: AR Classification: STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19026566).
BP6
Variant 1-230067374-G-T is Benign according to our data. Variant chr1-230067374-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 3098160.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALNT2NM_004481.5 linkc.94G>T p.Ala32Ser missense_variant Exon 1 of 16 ENST00000366672.5 NP_004472.1 Q10471-1A0A1L7NY50
GALNT2NR_120373.2 linkn.137G>T non_coding_transcript_exon_variant Exon 1 of 2
GALNT2NM_001291866.2 linkc.12+9296G>T intron_variant Intron 1 of 15 NP_001278795.1 Q10471G3V1S6B7Z6K2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALNT2ENST00000366672.5 linkc.94G>T p.Ala32Ser missense_variant Exon 1 of 16 1 NM_004481.5 ENSP00000355632.4 Q10471-1
GALNT2ENST00000488903.1 linkn.116G>T non_coding_transcript_exon_variant Exon 1 of 2 2
GALNT2ENST00000494106.1 linkn.89+9296G>T intron_variant Intron 1 of 6 5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
8.66e-7
AC:
1
AN:
1154718
Hom.:
0
Cov.:
29
AF XY:
0.00000177
AC XY:
1
AN XY:
563684
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22920
American (AMR)
AF:
0.00
AC:
0
AN:
12612
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16252
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24668
South Asian (SAS)
AF:
0.00
AC:
0
AN:
40716
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36144
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3866
European-Non Finnish (NFE)
AF:
0.00000105
AC:
1
AN:
953052
Other (OTH)
AF:
0.00
AC:
0
AN:
44488
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Mar 04, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
21
DANN
Benign
0.83
DEOGEN2
Benign
0.012
T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.40
T
M_CAP
Pathogenic
0.94
D
MetaRNN
Benign
0.19
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.42
N
PhyloP100
3.6
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
0.14
N
REVEL
Benign
0.10
Sift
Benign
0.52
T
Sift4G
Benign
0.74
T
Polyphen
0.0010
B
Vest4
0.18
MVP
0.45
MPC
0.49
ClinPred
0.089
T
GERP RS
2.9
PromoterAI
-0.076
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.9
Varity_R
0.040
gMVP
0.52
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr1-230203121; COSMIC: COSV107467365; API